- Report
- August 2025
- 195 Pages
Global
From €3496EUR$3,939USD£3,009GBP
- Report
- August 2025
- 196 Pages
Global
From €3496EUR$3,939USD£3,009GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,146GBP
Ceftibuten is an antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are used to treat a wide range of bacterial infections. Ceftibuten is used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to treat certain sexually transmitted diseases. Ceftibuten is available in both oral and injectable forms.
The ceftibuten market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. These companies offer a range of ceftibuten products, including tablets, capsules, and injections. Show Less Read more